Evidence map›Paper›PMID 35034191›Full record

ArticleVirchows Archiv : an international journal of pathology2022

Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven study.

Kim Van der Eecken, Malaïka Van der Linden, Lennart Raman, David Creytens, Franceska Dedeurwaerdere, Koen De Winne, Liesbeth Ferdinande, Martin Lammens, Björn Menten, Isabelle Rottiers and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Kim Van der Eecken *Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Malaïka Van der Linden *Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Lennart Raman *Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
David CreytensDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Franceska DedeurwaerdereDepartment of Pathology, AZ Delta, Roeselare, Belgium.
Koen De WinneDepartment of Pathology, Antwerp University Hospital, Antwerp, Belgium.
Liesbeth FerdinandeDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Martin LammensDepartment of Pathology, Antwerp University Hospital, Antwerp, Belgium.
Björn MentenCancer Research Institute (CRIG), Ghent, Belgium.
Isabelle RottiersDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Bram Van GaeverDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Caroline Van den BroeckeDepartment of Pathology, AZ Sint-Lucas, Ghent, Belgium.
Koen Van de VijverDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Nadine Van RoyCancer Research Institute (CRIG), Ghent, Belgium.
Sofie VerbekeDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Jo Van DorpeDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium. jo.vandorpe@uzgent.be.
Ghent University Hospital · BECancer Research Institute Ghent · BEAntwerp University Hospital · BEAZ Delta · BEAZ Sint-Lucas · BE

Funding

Bijzonder Onderzoeksfonds BOF.STA.2017.0002.01
6 · The paper itself

Abstract

Copy number alterations (CNAs) have increasingly become part of the diagnostic algorithm of glial tumors. Alterations such as homozygous deletion of CDKN2A/B, 7 +/ 10 - chromosome copy number changes or EGFR amplification are predictive of a poor prognosis. The codeletion of chromosome arms 1p and 19q, typically associated with oligodendroglioma, implies a more favorable prognosis. Detection of this codeletion by the current diagnostic standard, being fluorescence in situ hybridization (FISH), is sometimes however subject to technical and interpretation problems. In this study, we evaluated CNA detection by shallow whole-genome sequencing (sWGS) as an inexpensive, complementary molecular technique. A cohort of 36 glioma tissue samples, enriched with "difficult" and "ambiguous" cases, was analyzed by sWGS. sWGS results were compared with FISH assays of chromosomes 1p and 19q. In addition, CNAs relevant to glioblastoma diagnosis were explored. In 4/36 samples, EGFR (7p11.2) amplifications and homozygous loss of CDKN2A/B were identified by sWGS. Six out of 8 IDH-wild-type glioblastomas demonstrated a prognostic chromosome 7/chromosome 10 signature. In 11/36 samples, local interstitial and terminal 1p/19q alterations were detected by sWGS, implying that FISH's targeted nature might promote false arm-level extrapolations. In this cohort, differences in overall survival between patients with and without codeletion were better pronounced by the sequencing-based distinction (likelihood ratio of 7.48) in comparison to FISH groupings (likelihood ratio of 0.97 at diagnosis and 1.79 ± 0.62 at reobservation), suggesting sWGS is more accurate than FISH. We recognized adverse effects of tissue block age on FISH signals. In addition, we show how sWGS reveals relevant aberrations beyond the 1p/19q state, such as EGFR amplification, combined gain of chromosome 7 and loss of chromosome 10, and homozygous loss of CDKN2A/B. The findings presented by this study might stimulate implementation of sWGS as a complementary, easy to apply technique for copy number detection.

Indexed as

Brain NeoplasmsGliomaChromosome DeletionChromosomes, Human, Pair 19ErbB ReceptorsHomozygoteHumansIn Situ Hybridization, FluorescenceIsocitrate DehydrogenaseSequence DeletionErbB ReceptorsIsocitrate Dehydrogenase1p/19q codeletionCopy number aberration detectionFluorescence in situ hybridizationGlial tumorsShallow whole-genome sequencing

Identifiers

PMID35034191
OpenAlexW4205579874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.